Area of research
Cancer Research · Genetics
Research interest
Research interests include Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, BRCA gene mutations in cancer, and Gene expression and cancer classification.
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer
Association of the <scp> <i>CHEK2</i> </scp> c. <scp>1100delC</scp> variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
Rare Copy Number Variants (CNVs) and Breast Cancer Risk
Rare copy number variants (CNVs) and breast cancer risk
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Breast cancer quantitative proteome and proteogenomic landscape
Two truncating variants in FANCC and breast cancer risk
Identification of nine new susceptibility loci for endometrial cancer
Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
Body mass index and breast cancer survival: a Mendelian randomization analysis
Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity
<i>PHIP</i>- a novel candidate breast cancer susceptibility locus on 6q14.1
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer